Public procurement notice: Contract Notice
Published: 2017-10-14
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33181000 | 33181510 | 33181520 | 33600000: Pharmaceutical products
Estimated value: 15600000 GBP
Submission deadline: 2017-11-13
Award criteria: The most economic tender

Technical requirements: The framework agreement is for the supply and delivery of Peritoneal Dialysis fluids and consumables/ancillaries alongside the dialysis machines within NHS Scotland to hospitals and patients' homes or other designated address. Full details of the requirement will be available in the ITT.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
The framework agreement is for the supply and delivery of Peritoneal Dialysis fluids and consumables/ancillaries alongside the dialysis machines within NHS Scotland to hospitals and patients' homes or other designated address. Full details of the requirement will be available in the ITT.
The Authority intends to award an unranked multi supplier framework agreement to the most economically advantageous tenders.
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a)Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines prior to the commencement of the Framework Agreement.
(b)Potential Framework Participants must be able to demonstrate that all consumables/ancillaries and equipment supplied under this Framework are CE marked.
(c)All of the goods supplied under the Framework Agreement must be stored in and distributed from a site holding an MHRA Wholesaler Dealers Authorisation which covers POM medicines.
(d)Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(e)All of the dispensed Goods supplied under the Framework Agreement will be dispensed in a pharmacy which at the time of dispensing is registered with the General Pharmaceutical Council.
(f)All of the Pharmacist and Pharmacy Technician staff used to service this Framework Agreement will be registered with the General Pharmaceutical Council.
(g)All of the direct patient contact will be undertaken by staff, including all sub-contractors and couriers that, at the point of service provision, have Protecting Vulnerable Groups Scheme clearance in accordance with the prevailing regulations.
(h)All Clinical Services, as defined in the ITT/specification, must be undertaken by nursing staff, including all sub-contractors that, at the point of service provision, are qualified RNs (or RNCs as appropriate) with current Nursing and Midwifery Council registration.
(i)Where the provision of on-loan equipment applies, Framework Participants must be registered on the Health Facilities Scotland (HFS) Master Indemnity Agreement (MIA) List of Suppliers prior to the commencement of the Framework Agreement.
(a)Confirmation that a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines will be in place prior to the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control.

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 15600000